My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 487

    1.

    Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).

    Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, Puig A, Mejia R.

    Diabetes Care. 2007 Sep;30(9):2181-6. Epub 2007 May 18.PMID: 17513708 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Glycemic control in medical inpatients with type 2 diabetes mellitus receiving sliding scale insulin regimens versus routine diabetes medications: a multicenter randomized controlled trial.

    Dickerson LM, Ye X, Sack JL, Hueston WJ.

    Ann Fam Med. 2003 May-Jun;1(1):29-35.PMID: 15043177 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Comparison of once-daily glargine insulin with twice-daily NPH/regular insulin for control of hyperglycemia in inpatients after cardiovascular surgery.

    Yeldandi RR, Lurie A, Baldwin D.

    Diabetes Technol Ther. 2006 Dec;8(6):609-16.PMID: 17109592 [PubMed - indexed for MEDLINE]Related articles

    4.

    Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

    Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

    5.

    Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes.

    Umpierrez GE, Hor T, Smiley D, Temponi A, Umpierrez D, Ceron M, Munoz C, Newton C, Peng L, Baldwin D.

    J Clin Endocrinol Metab. 2009 Feb;94(2):564-9. Epub 2008 Nov 18.PMID: 19017758 [PubMed - indexed for MEDLINE]Related articles

    6.

    Can family physicians help patients initiate basal insulin therapy successfully?: randomized trial of patient-titrated insulin glargine compared with standard oral therapy: lessons for family practice from the Canadian INSIGHT trial.

    Harris S, Yale JF, Dempsey E, Gerstein H.

    Can Fam Physician. 2008 Apr;54(4):550-8.PMID: 18411384 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control.

    Grey NJ, Perdrizet GA.

    Endocr Pract. 2004 Mar-Apr;10 Suppl 2:46-52.PMID: 15251640 [PubMed - indexed for MEDLINE]Related articles

    8.

    Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

    Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

    Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Combination of oral antidiabetic agents with basal insulin versus premixed insulin alone in randomized elderly patients with type 2 diabetes mellitus.

    Janka HU, Plewe G, Busch K.

    J Am Geriatr Soc. 2007 Feb;55(2):182-8.PMID: 17302653 [PubMed - indexed for MEDLINE]Related articles

    10.

    Once-daily insulin glargine versus 6-hour sliding scale regular insulin for control of hyperglycemia after a bariatric surgical procedure: a randomized clinical trial.

    Datta S, Qaadir A, Villanueva G, Baldwin D.

    Endocr Pract. 2007 May-Jun;13(3):225-31.PMID: 17599852 [PubMed - indexed for MEDLINE]Related articles

    11.

    Long-term efficacy of insulin glargine after switching from NPH insulin as intensive replacement of basal insulin in Japanese diabetes mellitus. Comparison of efficacy between type 1 and type 2 diabetes (JUN-LAN Study 1.2).

    Kanazawa Y, Igarashi Y, Komiya K, Sakurai Y, Shimizu T, Fujitani Y, Tanaka Y, Watada H, Kawamori R, Hirose T.

    Endocr J. 2007;54(6):975-83. Epub 2007 Nov 14.PMID: 18000343 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.

    Barnett AH, Burger J, Johns D, Brodows R, Kendall DM, Roberts A, Trautmann ME.

    Clin Ther. 2007 Nov;29(11):2333-48.PMID: 18158075 [PubMed - indexed for MEDLINE]Related articles

    13.

    Validation of an insulin infusion nomogram for intensive glucose control in critically ill patients.

    Chant C, Wilson G, Friedrich JO.

    Pharmacotherapy. 2005 Mar;25(3):352-9.PMID: 15843282 [PubMed - indexed for MEDLINE]Related articles

    14.

    Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine.

    Bergenstal RM, Johnson M, Powers MA, Wynne A, Vlajnic A, Hollander P, Rendell M.

    Diabetes Care. 2008 Jul;31(7):1305-10. Epub 2008 Mar 25.PMID: 18364392 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    A pilot study to evaluate the effectiveness of glargine and multiple injections of lispro in patients with type 2 diabetes receiving tube feedings in a cardiovascular intensive care unit.

    Grainger A, Eiden K, Kemper J, Reeds D.

    Nutr Clin Pract. 2007 Oct;22(5):545-52.PMID: 17906278 [PubMed - indexed for MEDLINE]Related articles

    16.

    Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial.

    Umpierrez GE, Jones S, Smiley D, Mulligan P, Keyler T, Temponi A, Semakula C, Umpierrez D, Peng L, Cerón M, Robalino G.

    Diabetes Care. 2009 Jul;32(7):1164-9. Epub 2009 Apr 14.PMID: 19366972 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Efficacy and treatment satisfaction of once-daily insulin glargine plus one or two oral antidiabetic agents versus continuing premixed human insulin in patients with type 2 diabetes previously on long-term conventional insulin therapy: the Switch pilot study.

    Schiel R, Müller UA.

    Exp Clin Endocrinol Diabetes. 2007 Nov;115(10):627-33.PMID: 18058596 [PubMed - indexed for MEDLINE]Related articles

    18.

    Dosing of insulin glargine in the treatment of type 2 diabetes.

    Barnett A.

    Clin Ther. 2007 Jun;29(6):987-99. Review.PMID: 17692716 [PubMed - indexed for MEDLINE]Related articles

    19.

    Hyperglycemia management in the hospital setting.

    Hassan E.

    Am J Health Syst Pharm. 2007 May 15;64(10 Suppl 6):S9-S14.PMID: 17494893 [PubMed - indexed for MEDLINE]Related articles

    20.

    Once-daily insulin glargine compared with twice-daily NPH insulin in patients with type 1 diabetes.

    Hershon KS, Blevins TC, Mayo CA, Rosskamp R.

    Endocr Pract. 2004 Jan-Feb;10(1):10-7.PMID: 15251616 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity